CPRX - Company ID 0001369568
CATALYST PHARMACEUTICALS, INC. (CPRX) reported net income of $214.33M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $214.33M | +30.8% |
| FY 2024 | $163.89M | +129.5% |
| FY 2023 | $71.41M | -14.0% |
| FY 2022 | $83.08M | +110.4% |
| FY 2021 | $39.48M | -47.3% |
| FY 2020 | $74.98M | +135.2% |
| FY 2019 | $31.88M | +193.7% |
| FY 2018 | -$34.00M | -84.7% |
| FY 2017 |
CATALYST PHARMACEUTICALS, INC. (CPRX) reported net income of $214.33M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, CATALYST PHARMACEUTICALS, INC.'s net income grew from -$6.39M to $214.33M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$18.41M |
| -1.9% |
| FY 2016 | -$18.07M | +10.7% |
| FY 2015 | -$20.23M | -30.5% |
| FY 2014 | -$15.51M | -27.6% |
| FY 2013 | -$12.15M | -198.2% |
| FY 2012 | -$4.08M | +36.2% |
| FY 2011 | -$6.39M | - |